A detailed history of Baker Boyer National Bank transactions in Abbott Laboratories stock. As of the latest transaction made, Baker Boyer National Bank holds 1,850 shares of ABT stock, worth $220,057. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,850
Holding current value
$220,057
% of portfolio
0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$100.07 - $118.13 $185,129 - $218,540
1,850 New
1,850 $210,000
Q1 2024

Apr 12, 2024

SELL
$109.52 - $120.96 $11,718 - $12,942
-107 Reduced 5.47%
1,850 $210,000
Q4 2023

Jan 12, 2024

SELL
$90.19 - $110.4 $21,014 - $25,723
-233 Reduced 10.64%
1,957 $215,000
Q3 2023

Oct 12, 2023

BUY
$95.53 - $114.62 $209,210 - $251,017
2,190 New
2,190 $212,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Baker Boyer National Bank Portfolio

Follow Baker Boyer National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Boyer National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Baker Boyer National Bank with notifications on news.